Your session is about to expire
← Back to Search
Radiation Therapy
SCART radiation therapy for Cancer
Phase 1
Waitlist Available
Research Sponsored by Baptist Health, Louisville
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-6 months
Awards & highlights
Study Summary
A Phase I Study Evaluating the Safety of Stereotactic Central Ablative Radiation Therapy (SCART) for Bulky Metastatic or Recurrent Cancer
Eligible Conditions
- Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3-6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Toxicity
Secondary outcome measures
Assessment of the antitumor effect
Biomarkers
Evaluation of quality of life (QoL).
Trial Design
1Treatment groups
Experimental Treatment
Group I: SCART ArmExperimental Treatment1 Intervention
Single Arm patients will be treated with SCART to different dose levels.
Find a Location
Who is running the clinical trial?
Baptist Health, LouisvilleLead Sponsor
4 Previous Clinical Trials
1,791 Total Patients Enrolled
Drexel UniversityOTHER
150 Previous Clinical Trials
47,689 Total Patients Enrolled
Innovative InstituteUNKNOWN
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger